OLK / Olink Holding AB (publ) (OLK) CEO Jon Heimer on Q1 2022 Results - Earnings Call Transcript

Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences so more_horizontal

Olink Holding AB (publ) (NASDAQ:OLK ) Q2 2023 Earnings Conference Call August 9, 2023 8:00 AM ET Company Participants Jan Medina - VP, IR & Capital Ma more_horizontal

The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in Olink Holding AB (publ) Sponsored ADR (OLK). While t more_horizontal

Olink Holding AB (publ) (NASDAQ:OLK ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Jan Medina - Vice President of Inv more_horizontal

Olink Holding AB (publ) Sponsored ADR (OLK) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. more_horizontal

Olink Holding AB (publ) Sponsored ADR (OLK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earning more_horizontal

UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial resu more_horizontal

Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain ev more_horizontal